Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Nutrition & supportive carePRM 4620
Dosage formHard-gelatin capsules
Oral

5-Hydro Anthranilic Acid Hcl 0.2 mg, Biotin 30 mcg, Cholecalciferol 400 IU, Cyanocobalamin 2.5 mcg, DL-Methionine 18.4 mg, Folic Acid 0.50 mg, L-Arginine Hcl 13.28 mg, L-Histidine Hcl H2O 3.71 mg, L-Isoleucine 5.9 mg, L-Leucine 18.3 mg, L-Lysine Hcl 25 mg, L-Phenylalanine 5.0 mg, L-Threonine 4.2 mg, L-Tryptophan 5.0 mg, L-Valine 6.7 mg, Natural Betacarotene With Other Mixed Carotenoids 1000 mcg, Nicotinamide 25 mg, Pyridoxine Hcl 1.5 mg, Zinc Ascorbate 50 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Vitamin D / vitamin D analogue + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 5178
Dosage formSyrup
Oral

Absolute Alcohol 5% v/v, Biotin 300 mcg, Chromium 25 mcg, Copper 0.45 mg, Elemental Iodine 75 mcg, Elemental Zinc 7.5 mg, Iron 18 mg, L-Lysine MonoHcl 50 mg, Manganese 1.0 mg, Methylcobalamin 500 mcg, Niacinamide 45 mg, Selenium 40 mcg, Vitamin B6 1.5 mg / 15 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Iron replacement / haematinic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2599
Dosage formTablets
Oral

Acetyl Salicylic Acid 100 mg, Calcium Carbonate 30 mg, Citric Acid 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Salicylate analgesic / antiplatelet + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2601
Dosage formTablets
Oral

Acetylcysteine 25 mg, Biotin 1 mg, Chromium 200 mcg, Cyanocobalamin 15 mcg, Folic Acid 1 mg, Glutamic Acid 25 mg, Glycerine 25 mg, Inositol 50 mg, Nicotinamide 50 mg, Pyridoxine Hcl 3 mg, Selenium 100 mcg, Vanadium 100 mcg, Zinc 20 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Amino acid / metabolic nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 4630
Dosage formHard-gelatin capsules
Oral

Adenosine Triphosphate Disodium 20 mg, Idebenone 10 mg, L-Arginine 200 mg, Proanthocynidine 33 mg, Selenium 70 mcg, Zinc 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Mitochondrial electron-transfer / antioxidant agent + Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 4631
Dosage formHard-gelatin capsules
Oral

Adenosine Triphosphate Disodium 30 mg, Aescin 30 mg, Idebenone 15 mg, Methylcobalamin 750 mcg, Proanthocynidine 50 mg, Selenium 70 mcg, Zinc 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Mitochondrial electron-transfer / antioxidant agent + Venotonic / capillary-stabilising agent + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4632
Dosage formHard-gelatin capsules
Oral

Adenosyl Cobalamin 15 mcg, Carbonyl Iron 62 mg, Folic Acid 1500 ng, Zinc Oxide 25 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2620
Dosage formTablets
Oral

Adenosylcobalamin 15 mcg, Ferrous Ascorbate 100 mg, Folic Acid 1.5 mg, Zinc 22.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 4633
Dosage formHard-gelatin capsules
Oral

Adenosylcobalamin 500 mcg, Carbonyl Iron 100 mg, Folic Acid 1.5 mg, Zinc Sulphate Monohydrate 22.2 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Haematology & thrombosisPRM 2623
Dosage formTablets
Oral

Adenosylcobalamin 500 mcg, Folic Acid 500 mcg, Iron 100 mg, Zinc 27.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Iron replacement / haematinic + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2632
Dosage formTablets
Oral

ALA 100 mg, Benfotiamine 150 mg, Biotin 200 mcg, Calcium Carbonate 500 mg, Cr Picolinate 200 mcg, Folic Acid 1.5 mg, Inositol 100 mg, Methylcobalamin 1500 mcg, Pyridoxine 3 mg, Vit C 300 mg, Vit D3 2000 IU, Vit E 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 2637
Dosage formTablets
Oral

Alendronic Acid 70 mg, Calcium 500 mg, Cholecalciferol 250 IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Bisphosphonate + Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2639
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Betacarotene Dispersion 10 mg, Calcium 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2640
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium 200 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2641
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2642
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium Citrate 1000 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2643
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Calcium Citrate 250 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2644
Dosage formTablets
Oral

Alfacalcidol 0.25 mcg, Elemental Selenium 100 mcg, Elemental Zinc 7.5 mg, Folic Acid 1500 mcg, Inositol 100 mg, L-Arginine 500 mg, L-Carnitine L-Tartrate 50 mg, Piperine 2.5 mg, Ubidecarenone 10 mg, Vitamin B12 2.5 mcg, Vitamin B6 1.5 mg, Vitamin E 75 IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Vitamin D / vitamin D analogue + Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2645
Dosage formTablets
Oral

Alfacalcidol 0.5 mcg, Biotin 1.0 mg, Chromium Picolinate 500 mcg, N-Acetyl L-Cysteine 600 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Mucolytic + Vitamin D / vitamin D analogue + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 4639
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 15 mg, Calcium Pantothenate 25 mg, Chromium Picolinate 65 mcg, Folic Acid 1.5 mg, Inositol 10 mcg, Lutein 5 mg, Methylcobalamin 1500 mcg, Vitamin B 63 mg, Zinc Oxide 22.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 4640
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 15 mg, Calcium Pantothenate 25 mg, Chromium Picolinate 65 mcg, Folic Acid 1.5 mg, Inositol 10 mcg, Lutein 5 mg, Methylcobalamin 1500 mcg, Vitamin B6 3 mg, Zinc Oxide 22.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 4641
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Benfotiamine 50 mg, Biotin 5 mg, Chromium 200 mcg, Folic Acid 1.5 mg, Methylcobalamin 1500 mcg, Vitamin B6 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2671
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Beta Carotene 5.17 mcg, Calcium Pantothenate 5 mg, Chromium Picolinate 2.5 mg, Copper Sulphate 15 mg, Folic Acid 50 mg, Lutein 1 mg, Manganese Sulphate 60 mcg, Methylcobalamin 500 mcg, Niacinamide 25 mg, Selenium Dioxide 1.4 mg, Vitamin B1 2 mg, Vitamin B2 2 mg, Vitamin B6 1.5 mg, Vitamin C 50 mg, Vitamin D3 200 IU, Vitamin E 10 IU, Zinc Oxide 65 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Nutrition & supportive carePRM 2672
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Biotin 100 mcg, Chromium 60 mcg, Folic Acid 1.5 mg, Inositol 2 mg, Methylcobalamin 1500 mcg, Selenium 65 mcg, Vitamin B6 3 mg, Zinc 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product